QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.107.122218v1 322/2/600    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheung, Y.-F. Articles by Castle, J. C. Search for Related Content PubMed PubMed Citation Articles by Cheung, Y.-F. Articles by Castle, J. C. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide Protein UniGene Compound via MeSH Substance via MeSH

CELLULAR AND MOLECULAR

PDE4B5, a Novel, Super-Short, Brain-Specific cAMP Phosphodiesterase-4 Variant Whose Isoform-Specifying N-Terminal Region Is Identical to That of cAMP Phosphodiesterase-4D6 (PDE4D6)

Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom (Y.-F.C., I.G., H.M., G.S.B., M.D.H.); Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck & Co., Inc., Seattle, Washington (Z.K., P.G.-E., J.M.J., J.C.C.); and Merck Research Laboratories, Boston, Massachusetts (L.M.C.)

The cAMP-specific phosphodiesterase-4 (PDE4) gene family is the target of several potential selective therapeutic inhibitors. The four PDE4 genes generate several distinct protein-coding isoforms through the use of alternative promoters and 5'-coding exons. Using mouse transcripts, we identified a novel, super-short isoform of human PDE4B encoding a novel 5' terminus, which we label PDE4B5. The protein-coding region of the novel 5' exon is conserved across vertebrates, chicken, zebrafish, and fugu. Reverse-transcription-polymerase chain reaction (PCR) and quantitative (PCR) measurements show that this isoform is brain-specific. The novel protein is 58 ± 2 kDa; it has cAMP hydrolyzing enzymatic activity and is inhibited by PDE4-selective inhibitors rolipram and cilomilast (Ariflo). Confocal and subcellular fractionation analyses show that it is distributed predominantly and unevenly within the cytosol. The 16 novel N-terminal residues of PDE4B5 are identical to the 16 N-terminal residues of the super-short isoform of PDE4D (PDE4D6), which is also brain-specific. PDE4B5 is able to bind the scaffold protein DISC1, whose gene has been linked to schizophrenia. Microarray expression profiling of the PDE4 gene family shows that specific PDE4 genes are enriched in muscle and blood fractions; however, only by monitoring the individual isoforms is the brain specificity of the super-short PDE4D and PDE4B isoforms revealed. Understanding the distinct tissue specificity of PDE4 isoforms will be important for understanding phosphodiesterase biology and opportunities for therapeutic intervention.

Address correspondence to: Dr. John C. Castle, Rosetta Inpharmatics, 401 Terry Ave. North, Seattle, WA. E-mail: john_castle{at}merck.com

This article has been cited by other articles:

				T. B. Halene and S. J. Siegel Antipsychotic-Like Properties of Phosphodiesterase 4 Inhibitors: Evaluation of 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with Auditory Event-Related Potentials and Prepulse Inhibition of Startle J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 230 - 239. [Abstract] [Full Text] [PDF]

				U. Tawar, K. Kotlo, S. Jain, S. Shukla, S. Setty, and R. S. Danziger Renal Phosphodiesterase 4B Is Activated in the Dahl Salt-Sensitive Rat Hypertension, March 1, 2008; 51(3): 762 - 766. [Abstract] [Full Text] [PDF]

				J. K. Millar, S. Mackie, S. J. Clapcote, H. Murdoch, B. S. Pickard, S. Christie, W. J. Muir, D. H. Blackwood, J. C. Roder, M. D. Houslay, et al. Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illness J. Physiol., October 15, 2007; 584(2): 401 - 405. [Abstract] [Full Text] [PDF]